AlphaYouEL
Insider selling
Evan Lippman sold $1.5M of Teva Pharmaceutical Industries Ltd (TEVA) stock
Evan Lippman, EVP, Business Development of Teva Pharmaceutical Industries Ltd (TEVA), sold 41,658 shares of TEVA stock worth $1.5M, per an SEC Form 4 filed May 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 14, 2026, 4 days before it was made public.
TEVA has moved +13.5% since the trade date, from $35.31 to $40.06 (Sep 21, 2026 close).
- Traded
- May 14, 2026
- Disclosed
- May 18, 2026
- Filing delay
- 4 days
- Price since
- +13.5%
- Role
- EVP, Business Development
- Source
- SEC Form 4
More TEVA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.